The veterinary oncology market refers to the field of veterinary medicine that specializes in the diagnosis and treatment of cancer in animals. It is an important area of veterinary medicine because cancer is one of the leading causes of death in pets.

The veterinary oncology market was estimated at US$ 222 million in 2021 and is expected to grow at a CAGR of 11.88% during 2022-2028 to reach US$ 489.87 million in 2028. The market for veterinary oncology has grown rapidly in recent years, driven by several factors. One factor is the increasing number of pet owners who are willing to pay for cancer treatment for their pets. As pets have become more like members of the family, many pet owners are willing to spend significant amounts of money to keep their pets healthy and comfortable, including paying for cancer treatment.

Another factor driving growth in the veterinary oncology market is the development of new treatments and technologies. Advances in chemotherapy, radiation therapy, and immunotherapy have made it possible to treat many types of cancer in pets, and new treatments are being developed all the time. In addition, there has been a growing trend towards personalized medicine in veterinary oncology, with veterinarians using genetic testing and other tools to tailor treatment plans to individual pets.

Request a sample here:

https://www.stratviewresearch.com/Request-Sample/3192/veterinary-oncology-market.html#form

The veterinary oncology market is also benefiting from increased awareness of the importance of cancer screening and early detection in pets. Regular check-ups and cancer screening can help identify cancer at an early stage when it is more treatable, and many veterinarians now offer cancer screening as part of routine care.

However, there are also challenges facing the veterinary oncology market. One challenge is the cost of cancer treatment, which can be prohibitively expensive for many pet owners. In addition, there is a shortage of veterinary oncologists and other specialists in many areas, which can make it difficult for pet owners to access the best possible care for their pets.

Despite these challenges, the veterinary oncology market is expected to continue to grow in the coming years. As the pet population continues to increase and pets continue to play a more important role in people's lives, the demand for cancer treatment for pets is likely to increase as well. Advances in technology and the development of new treatments will also drive growth in the market, as will efforts to increase awareness of the importance of cancer screening and early detection in pets.

North America dominated the veterinary oncology market in 2021. During the forecast period, the sector is expected to dominate the market. The presence of a significant number of pet drug manufacturing companies, as well as the rapid acceptance of novel pet care treatments, are major factors contributed to market growth.

The following are the major players in the veterinary oncology market:

• PetCure Oncology
• Zoetis
• Karyopharm Therapeutics, Inc.
• Varian Medical Systems
• Accuray Incorporated
• Boehringer Ingelheim GmbH
• Elanco
• One Health
• Regeneus Ltd

In conclusion, the veterinary oncology market is an important and growing field of veterinary medicine. While there are challenges facing the market, including the cost of treatment and a shortage of specialists, the increasing demand for cancer treatment for pets, as well as advances in technology and awareness of the importance of cancer screening, are likely to drive continued growth in the market.